ESH AL 2018 | Important stratifications for the treatment of ALL

Name: Important stratifications for the treatment of ALL
Uploaded: 2018-05-04T00:00:00.000Z
Duration: 2 min 9 s
Description: Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, Torsten Haferlach, MD, of MLL Munich Leukemia Laboratory, Munich, Germany, states his opinions as to which stratifications are the most important to inform treatment decisions in the early treatment of acute lymphoblastic leukemia (ALL).

Torsten Haferlach • 4 May 2018

ESH AL 2018

Acute Lymphoblastic Leukemia Leukemia

Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, Torsten Haferlach, MD, of MLL Munich Leukemia Laboratory, Munich, Germany, states his opinions as to which stratifications are the most important to inform treatment decisions in the early treatment of acute lymphoblastic leukemia (ALL).